NLRP7, Molar Pregnancy, and Recurrent Loss: What the Gene Explains

Some losses come with a specific, disorienting diagnosis: a molar pregnancy, where a pregnancy develops as an abnormal mass of placental tissue rather than a viable pregnancy. When it happens more than once, the question becomes whether something inherited is driving it — and for many families, the answer involves a gene called NLRP7.

This is a narrower, more defined situation than general pregnancy loss, and that is exactly why it is worth explaining clearly. NLRP7 is the best-understood cause of recurrent molar pregnancy, and understanding it changes what "unexplained" means for the families it affects.

What a molar pregnancy is

A molar pregnancy (hydatidiform mole) is an abnormal pregnancy in which the placental tissue overgrows and no healthy fetus develops. It is not viable, and it needs medical attention in its own right, because molar tissue requires monitoring and management. Most molar pregnancies are one-time events caused by an abnormal combination of chromosomes at fertilization.

A smaller group is different. In recurrent molar pregnancy, the moles keep happening, and — unusually — the tissue carries a normal, biparental set of chromosomes (one set from each parent), rather than the all-paternal chromosomes seen in typical moles. That combination, normal chromosomes but molar development, is the signature that points toward a maternal-effect gene like NLRP7.

What NLRP7 does, and what "maternal-effect" means

A maternal-effect gene is one where the mother's genotype — acting through the egg she produces — determines how the early embryo develops, regardless of the embryo's own genes. The egg is stocked in advance with proteins and instructions; if a maternal-effect gene is faulty, that starter kit is incomplete, and development goes wrong from the outset.

NLRP7 is a central player in that starter kit. It helps regulate genomic imprinting — the process that marks which genes should be active depending on whether they came from the mother or the father. When NLRP7 is disrupted, those marks are not established correctly, and the balance that a normal pregnancy depends on is lost, producing molar development or early loss instead.

Why it recurs — even with a different partner

This is the part that surprises people. Recurrent molar pregnancy from NLRP7 is usually autosomal recessive: a woman who has two altered copies of the gene is affected, and the problem originates in her eggs (van der Molen et al., European Journal of Human Genetics, 2018). Because the driver is in the egg rather than the sperm, changing partners does not change the outcome — which is often how families and clinicians first suspect a maternal-effect cause.

NLRP7 accounts for the large majority of recurrent molar pregnancy cases, with variants reported in roughly half to three-quarters of affected women in studied groups; a related gene, KHDC3L, explains a smaller share. Beyond classic moles, alterations in these maternal-effect genes have also been linked to recurrent miscarriage and stillbirth in some families, though that broader picture is still being defined.

What testing can and cannot tell you

For someone with recurrent molar pregnancy — or recurrent loss with molar features — sequencing NLRP7 (and related genes) can offer a real explanation where standard testing comes back unrevealing. A confirmed finding can:

• Explain why the pattern is repeating, and why partner changes have not helped.
• Clarify the recessive inheritance pattern for a family, which can matter for relatives.
• Support a focused conversation about reproductive options with a specialist, which for some families includes egg donation.

The limits are just as important. A finding is not a diagnosis on its own, it does not predict the outcome of any single future pregnancy, and molar pregnancies still require their own clinical monitoring regardless of genetics. This is information to interpret with a clinician and genetic counselor, not a standalone answer.

Where Reticular fits

NLRP7 is one of the genes on Reticular's parent-only reproductive screen, which reviews saliva from one or both intended parents for rare variants tied to fertility, early development, and pregnancy loss. Because NLRP7-related loss is recessive and egg-driven, screening the person carrying the pregnancy is central, and counseling is included to put any finding in context.

It is worth stating the boundary plainly: this screening does not replace the clinical management of a molar pregnancy, standard carrier screening, or karyotyping, and a finding is not a diagnosis or a treatment plan. For how a molar or recurrent-loss workup fits alongside other genetic testing, see Recurrent Pregnancy Loss: The Genetic Workup Beyond a Karyotype.